FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Bernard Lemieux

Research Profile

Living Beings

Procedures

Geographic Areas

Disorders

Chemicals & Drugs

Concepts & Ideas

Phenomena

False Positive Reactions

Co-author Network

Publications

TOP 3
Denis Cyr; Robert Giguère; Gaëlle Villain; Bernard Lemieux; Régen Drouin
A GC/MS validated method for the nanomolar range determination of succinylacetone in amniotic fluid and plasma: an analytical tool for tyrosinemia type I.
Lee Soderstrom; William G Woods; Mark Bernstein; Leslie L Robison; Mendel Tuchman; Bernard Lemieux
Health and economic benefits of well-designed evaluations: some lessons from evaluating neuroblastoma screening.
Caroline Patry; Bernard Lemieux; Raymund J Wellinger; Benoit Chabot
Targeting heterogeneous nuclear ribonucleoparticule A1 and A2 proteins by RNA interference promotes cell death in transformed but not in normal mouse cell lines.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Bernard Lemieux (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Denis Cyr; Robert Giguère; Gaëlle Villain; Bernard Lemieux; Régen Drouin
A GC/MS validated method for the nanomolar range determination of succinylacetone in amniotic fluid and plasma: an analytical tool for tyrosinemia type I.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2006;832(1):24-9.
2005: Lee Soderstrom; William G Woods; Mark Bernstein; Leslie L Robison; Mendel Tuchman; Bernard Lemieux
Health and economic benefits of well-designed evaluations: some lessons from evaluating neuroblastoma screening.
Journal of the National Cancer Institute 2005;97(15):1118-24.
2004: Caroline Patry; Bernard Lemieux; Raymund J Wellinger; Benoit Chabot
Targeting heterogeneous nuclear ribonucleoparticule A1 and A2 proteins by RNA interference promotes cell death in transformed but not in normal mouse cell lines.
Molecular cancer therapeutics 2004;3(10):1193-9.
2003: Caroline Patry; Louise Bouchard; Pascale Labrecque; Daniel Gendron; Bernard Lemieux; Johanne Toutant; Elvy Lapointe; Raymund J Wellinger; Benoit Chabot
Small interfering RNA-mediated reduction in heterogeneous nuclear ribonucleoparticule A1/A2 proteins induces apoptosis in human cancer cells but not in normal mortal cell lines.
Cancer research 2003;63(22):7679-88.
2003: Christiane Auray-Blais; Robert Giguère; Bernard Lemieux
Newborn urine screening programme in the province of Quebec: an update of 30 years' experience.
Journal of inherited metabolic disease 2003;26(4):393-402.
2002: William G Woods; Ru-Nie Gao; Jonathan J Shuster; Leslie L Robison; Mark Bernstein; Sheila Weitzman; Greta Bunin; Isra Levy; Jean-Hugues Brossard; Geoffrey Dougherty; Mendel Tuchman; Bernard Lemieux
Screening of infants and mortality due to neuroblastoma.
The New England journal of medicine 2002;346(14):1041-6.
2001: L Fang; N Chalhoub; W Li; Josué Feingold; June Ortenberg; Bernard Lemieux; Jean-Paul Thirion
Genotype analysis of the NF1 gene in the French Canadians from the Québec population.
American journal of medical genetics 2001;104(3):189-98.
2001: Li Juan Fang; Martin J Simard; Dominique Vidaud; B Assouline; Bernard Lemieux; Michel Vidaud; Benoit Chabot; Jean-Paul Thirion
A novel mutation in the neurofibromatosis type 1 (NF1) gene promotes skipping of two exons by preventing exon definition.
Journal of molecular biology 2001;307(5):1261-70.
2001: Garrett M Brodeur; A Thomas Look; H Shimada; V M Hamilton; John M Maris; H W Hann; Jean-Marie Leclerc; Mark Bernstein; LC Brisson; Jean-Hugues Brossard; Bernard Lemieux; Mendel Tuchman; William G Woods
Biological aspects of neuroblastomas identified by mass screening in Quebec.
Medical and pediatric oncology 2001;36(1):157-9.
2000: Denis Cyr; Robert Giguère; Y Giguère; Bernard Lemieux
Determination of urinary acylcarnitines: a complementary aid for the high-risk screening of several organic acidurias using a simple and reliable GC/MS-based method.
Clinical biochemistry 2000;33(2):151-5.
1999: William G Woods; Mark Bernstein; Bernard Lemieux
Randomized controlled trials in population-based intervention studies are not always feasible.
Medical and pediatric oncology 1999;33(4):360-1.
1999: L C Sniderman; M Lambert; Robert Giguère; Christiane Auray-Blais; Bernard Lemieux; R Laframboise; D S Rosenblatt; Eileen P Treacy
Outcome of individuals with low-moderate methylmalonic aciduria detected through a neonatal screening program.
The Journal of pediatrics 1999;134(6):675-80.
1999: Li Juan Fang; Josué Feingold; Bernard Lemieux; Jean-Paul Thirion
A novel and very peculiar HincII polymorphism in the 5' region of the human neurofibromatosis type 1 (NF1) gene.
Annales de génétique 1999;42(4):231-3.
1998: T Kawakami; Y Monobe; H Monforte; W G Woods; M Tuchman; Bernard Lemieux; LC Brisson; M Bernstein; Jean-Hugues Brossard; Jean-Marie Leclerc; T D Byrne; Timothy Triche; H Shimada
Pathology review of screening negative neuroblastomas: a report from the Quebec Neuroblastoma Screening Project.
Cancer 1998;83(3):575-81.
1998: P Campion; William G Woods; Bernard Lemieux
Compliance in a screening program for neuroblastoma.
Preventive medicine 1998;27(4):590-6.
1997: William G Woods; Mendel Tuchman; L L Robison; M Bernstein; Jean-Marie Leclerc; LC Brisson; Jean-Hugues Brossard; G Hill; J Shuster; Russell V Luepker; T Byrne; S Weitzman; G Bunin; Bernard Lemieux; Garrett M Brodeur
Screening for neuroblastoma is ineffective in reducing the incidence of unfavourable advanced stage disease in older children.
European journal of cancer (Oxford, England : 1990) 1997;33(12):2106-12.
1997: Denis Cyr; Robert Giguère; Mendel Tuchman; Bernard Lemieux
Stability of urinary HVA and VMA on filter paper.
Early human development 1997;49(2):149-52.
1996: William G Woods; Mendel Tuchman; Leslie L Robison; M Bernstein; Jean-Marie Leclerc; L C Brisson; Jean-Hugues Brossard; G Hill; J Shuster; Russell V Luepker; T Byrne; S Weitzman; G Bunin; Bernard Lemieux
A population-based study of the usefulness of screening for neuroblastoma.
Lancet 1996;348(9043):1682-7.
1996: MT McCann; M M Thompson; I C Gueron; Bernard Lemieux; Robert Giguère; Mendel Tuchman
Methylmalonic acid quantification by stable isotope dilution gas chromatography-mass spectrometry from filter paper urine samples.
Clinical chemistry 1996;42(6 Pt 1):910-4.
1995: L A Takeuchi; Y Hachitanda; William G Woods; Mendel Tuchman; Bernard Lemieux; L Brisson; M Bernstein; Jean-Hugues Brossard; Jean-Marie Leclerc; T D Byrne
Screening for neuroblastoma in North America. Preliminary results of a pathology review from the Quebec Project.
Cancer 1995;76(11):2363-71.
1994: William G Woods; Bernard Lemieux; Jean-Marie Leclerc; Mark L Bernstein; L Brisson; Jean-Hugues Brossard; G M Brodeur; A T Look; Leslie L Robison; J J Shuster
Screening for neuroblastoma (NB) in North America: the Quebec Project.
Progress in clinical and biological research 1994;385():377-82.
1993: Bernard Lemieux; R Giguere; D Cyr; D Shapcott; M McCann; Mendel Tuchman
Screening urine of 3-week-old newborns: lack of association between sudden infant death syndrome and some metabolic disorders.
Pediatrics 1993;91(5):986-8.
1992: Mendel Tuchman; MT McCann; M M Thompson; Michael Y Tsai; R Giguere; Bernard Lemieux
Screening urine of 3-week-old newborns: transient methylmalonic and hydroxyphenyllactic aciduria.
Biochemical medicine and metabolic biology 1992;48(1):64-8.
1992: J L Michaud; Bernard Lemieux; H Ogier; M A Lambert
Nutritional vitamin B12 deficiency: two cases detected by routine newborn urinary screening.
European journal of pediatrics 1992;151(3):218-20.
1992: William G Woods; Bernard Lemieux; Mendel Tuchman
Neuroblastoma represents distinct clinical-biologic entities: a review and perspective from the Quebec Neuroblastoma Screening Project.
Pediatrics 1992;89(1):114-8.
1991: Mendel Tuchman; MT McCann; P E Johnson; Bernard Lemieux
Screening newborns for multiple organic acidurias in dried filter paper urine samples: method development.
Pediatric research 1991;30(4):315-21.
1991: William G Woods; Mendel Tuchman; Bernard Lemieux
Screening for neuroblastoma in North America--preliminary results from the Quebec project.
Progress in clinical and biological research 1991;366():585-94.
1990: Mendel Tuchman; Bernard Lemieux; C Auray-Blais; Leslie L Robison; R Giguere; MT McCann; William G Woods
Screening for neuroblastoma at 3 weeks of age: methods and preliminary results from the Quebec Neuroblastoma Screening Project.
Pediatrics 1990;86(5):765-73.
1990: A Michalak; M A Lambert; Louis Dallaire; S B Melançon; R Laframboise; Bernard Lemieux; Ijaz Qureshi
[Hypocarnitinemia in patients affected by a primary defect of ammonia metabolism treated with sodium benzoate].
Diabète & métabolisme 1990;16(3):226-33.
1989: Bernard Lemieux; C Auray-Blais; Robert Giguère; Charles R Scriver
Neuroblastoma screening: the Canadian experience.
Medical and pediatric oncology 1989;17(5):379-81.
1989: C Auray-Blais; Robert Giguère; Bernard Lemieux
Thin-layer chromatography of urinary homovanillic acid and vanillylmandelic acid for large-scale neuroblastoma mass screening.
Medical and pediatric oncology 1989;17(5):364-7.
1989: G Dunkel; Charles R Scriver; C L Clow; S Melançon; Bernard Lemieux; A Grenier; C Laberge
Prospective ascertainment of complete and partial serum biotinidase deficiency in the newborn.
Journal of inherited metabolic disease 1989;12(2):131-8.
1988: Bernard Lemieux; C Auray-Blais; Robert Giguère; D Shapcott; Charles R Scriver
Newborn urine screening experience with over one million infants in the Quebec Network of Genetic Medicine.
Journal of inherited metabolic disease 1988;11(1):45-55.
1987: Mendel Tuchman; C Auray-Blais; M L Ramnaraine; Joseph P Neglia; W Krivit; Bernard Lemieux
Determination of urinary homovanillic and vanillylmandelic acids from dried filter paper samples: assessment of potential methods for neuroblastoma screening.
Clinical biochemistry 1987;20(3):173-7.
1987: Charles R Scriver; D Gregory; M Bernstein; C L Clow; T Weisdorf; G E Dougherty; C Auray-Blais; Robert Giguère; Bernard Lemieux; C Laberge
Feasibility of chemical screening of urine for neuroblastoma case finding in infancy in Quebec.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1987;136(9):952-6.
1987: M Charbonneau; C Laberge; Charles R Scriver; J H Dussault; Bernard Lemieux; S Melançon
The Quebec Network of Genetic Medicine.
Canadian journal of public health. Revue canadienne de santé publique 1987;78(2):79-83.
1985: Charles R Scriver; C L Clow; T M Reade; Paul Goodyer; C Auray-Blais; Robert Giguère; Bernard Lemieux
Ontogeny modifies manifestations of cystinuria genes: implications for counseling.
The Journal of pediatrics 1985;106(3):411-6.
1984: Bernard Lemieux; C Auray-Blais; R Giguere; D Shapcott
Prolidase deficiency: detection of cases by a newborn urinary screening programme.
Journal of inherited metabolic disease 1984;7 Suppl 2():145-6.
1982: Bernard Lemieux; C Auray-Blais; Robert Giguère
Comparison between amino acids and orotic acid analysis in the detection of urea cycle disorders in the Quebec Urinary Screening Program.
Advances in experimental medicine and biology 1982;153():321-9.
1980: D Paradis; R Giguere; C Auray-Blais; P Draper; Bernard Lemieux
An automated method for the determination of orotic acid in the urine of children being screened for metabolic disorders.
Clinical biochemistry 1980;13(4):160-3.
1980: R Giguere; C Auray-Blais; P Draper; Bernard Lemieux
Diet and medications giving positive ninhydrin reactions on TLC in a newborn urinary screening program.
Clinical biochemistry 1980;13(3):103-5.